-+ 0.00%
-+ 0.00%
-+ 0.00%

Pyxis Oncology appoints Nelson Azoulay chief business officer

PUBT·05/07/2026 20:18:15
Listen to the news
Pyxis Oncology appoints Nelson Azoulay chief business officer
  • Pyxis Oncology named Nelson Azoulay as chief business officer.
  • Role includes leading corporate development strategy, pursuing strategic opportunities tied to MICVO, company’s lead clinical asset.
  • Azoulay previously served as senior vice president of strategy and business development at Flagship Pioneering.
  • Earlier roles include vice president of corporate development at ImmunoGen, where he supported fundraising, led transactions, contributed to collaborations with large pharmaceutical partners, worked on ImmunoGen acquisition by AbbVie, subsequent integration in 2024.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605071605PRIMZONEFULLFEED9715533) on May 07, 2026, and is solely responsible for the information contained therein.